Correlation Between Crescita Therapeutics and Cannabis Global

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crescita Therapeutics and Cannabis Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crescita Therapeutics and Cannabis Global into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crescita Therapeutics and Cannabis Global, you can compare the effects of market volatilities on Crescita Therapeutics and Cannabis Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crescita Therapeutics with a short position of Cannabis Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crescita Therapeutics and Cannabis Global.

Diversification Opportunities for Crescita Therapeutics and Cannabis Global

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Crescita and Cannabis is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Crescita Therapeutics and Cannabis Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Global and Crescita Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crescita Therapeutics are associated (or correlated) with Cannabis Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Global has no effect on the direction of Crescita Therapeutics i.e., Crescita Therapeutics and Cannabis Global go up and down completely randomly.

Pair Corralation between Crescita Therapeutics and Cannabis Global

Assuming the 90 days horizon Crescita Therapeutics is expected to generate 15.71 times less return on investment than Cannabis Global. But when comparing it to its historical volatility, Crescita Therapeutics is 4.06 times less risky than Cannabis Global. It trades about 0.05 of its potential returns per unit of risk. Cannabis Global is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  0.07  in Cannabis Global on November 2, 2024 and sell it today you would lose (0.06) from holding Cannabis Global or give up 85.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.4%
ValuesDaily Returns

Crescita Therapeutics  vs.  Cannabis Global

 Performance 
       Timeline  
Crescita Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Crescita Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Cannabis Global 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Global are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Cannabis Global disclosed solid returns over the last few months and may actually be approaching a breakup point.

Crescita Therapeutics and Cannabis Global Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crescita Therapeutics and Cannabis Global

The main advantage of trading using opposite Crescita Therapeutics and Cannabis Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crescita Therapeutics position performs unexpectedly, Cannabis Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Global will offset losses from the drop in Cannabis Global's long position.
The idea behind Crescita Therapeutics and Cannabis Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities